Predicate |
Object |
assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_26b39c28281c42b57614759aa776aff0 http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_50f69df95966af35084db94b0173ae19 |
classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07K5-02 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K38-02 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P5-02 |
filingDate |
2011-02-04-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_986eeb195b1e9eedf0d455c28392c659 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_86f3df0b9576403b041e1400b6962147 |
publicationDate |
2011-07-29-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
publicationNumber |
RO-126462-A0 |
titleOfInvention |
RICE CARDIOLOGICAL POLYPYLUE |
abstract |
The invention relates to a pharmaceutical preparation for the prevention of cardiovascular diseases. The preparation according to the invention comprises 4 to 12 mg of a rosuvastatin-type HMG-CoA reductase inhibitor, 4 to 12 mg of a ivabradine-type If channel inhibitor, 60 ... 110 mg of an inhibitor of the clopidogrel-type ADP platelets ADP receptor and 10-30 mg of a selective eplerenone corticoid receptor selective blocker. |
priorityDate |
2011-02-04-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
type |
http://data.epo.org/linked-data/def/patent/Publication |